MVA-209-FSPs | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

8,662 results for “MVA-209-FSPs”

Trials

View all 5544 →

Active, not recruiting

Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors

115 participants · First posted Aug 1, 2019

Active, not recruiting

Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients

45 participants · First posted Oct 15, 2021

Safety and Pharmacokinetics of ODM-209

38 participants · First posted Mar 18, 2019

Drugs

View all 2409 →

NOUS-209

MV-209

Investigational

MVA-mBN226B

Organizations

View all 46 →

Oncorena AB

Norway

Vallon Pharmaceuticals, Inc.

United States

Providence Health & Services

United States

News

View all 663 →

NOUS-209 Neoantigen Vaccine Shows Promise for Cancer Prevention in Lynch Syndrome Carriers

Nouscom's NOUS-209 Shows Promising Results in Cancer Interception for Lynch Syndrome Patients

Nouscom's NOUS-209 Shows Promise in Anti-PD-1 Resistant MSI-H Colorectal Cancer

Page 1 of 867